Search Reports
Categories
Categories

Global Immunotherapy Market

Global Immunotherapy Market Research Report 2025(Status and Outlook)

Report Code : MEC0981
Published Date : 17 July, 1905 | No of Pages: 141

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Immunotherapy refers to a class of treatments that harness the body\'s immune system to fight diseases, particularly cancer, by either stimulating immune responses or introducing engineered immune components like checkpoint inhibitors, CAR-T cells, or monoclonal antibodies. Unlike traditional therapies such as chemotherapy or radiation, which directly target cancer cells, immunotherapy enhances the immune system\'s ability to identify and destroy malignant cells, often with fewer side effects and longer-lasting efficacy. The market includes various modalities, such as immune checkpoint inhibitors (e.g., PD-1/PD-L1 and CTLA-4 inhibitors), adoptive cell therapies (e.g., CAR-T and TCR therapies), cancer vaccines, and cytokine-based treatments. Growth is driven by increasing cancer prevalence, advancements in personalized medicine, and rising R&D investments, though challenges like high costs, complex manufacturing, and variable patient responses persist. Key players include pharmaceutical giants like Merck, Bristol-Myers Squibb, and Novartis, alongside biotech innovators. The market is expanding into new applications, including autoimmune diseases and infectious diseases, further broadening its scope. Regulatory approvals, strategic collaborations, and biomarker-driven approaches are shaping competitive dynamics, with North America leading in adoption and Asia-Pacific emerging as a high-growth region due to improving healthcare infrastructure and rising demand.

The global Immunotherapy market size was estimated at USD 16648.79 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.34% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Immunotherapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Immunotherapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Immunotherapy market.
Global Immunotherapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbvie
AmgenInc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche

Market Segmentation (by Type)
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy

Market Segmentation (by Application)
Oncology
Inflammation
Central Nervous System
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Immunotherapy Market
Overview of the regional outlook of the Immunotherapy Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immunotherapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Immunotherapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Immunotherapy
      1.2 Key Market Segments
            1.2.1 Immunotherapy Segment by Type
            1.2.2 Immunotherapy Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Immunotherapy Market Overview
      2.1 Global Market Overview
            2.1.1 Global Immunotherapy Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Immunotherapy Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Immunotherapy Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Immunotherapy Product Life Cycle
      3.3 Global Immunotherapy Sales by Manufacturers (2020-2025)
      3.4 Global Immunotherapy Revenue Market Share by Manufacturers (2020-2025)
      3.5 Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Immunotherapy Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Immunotherapy Market Competitive Situation and Trends
            3.8.1 Immunotherapy Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Immunotherapy Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Immunotherapy Industry Chain Analysis
      4.1 Immunotherapy Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Immunotherapy Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Immunotherapy Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Immunotherapy Market
      5.7 ESG Ratings of Leading Companies
  6 Immunotherapy Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Immunotherapy Sales Market Share by Type (2020-2025)
      6.3 Global Immunotherapy Market Size Market Share by Type (2020-2025)
      6.4 Global Immunotherapy Price by Type (2020-2025)
  7 Immunotherapy Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Immunotherapy Market Sales by Application (2020-2025)
      7.3 Global Immunotherapy Market Size (M USD) by Application (2020-2025)
      7.4 Global Immunotherapy Sales Growth Rate by Application (2020-2025)
  8 Immunotherapy Market Sales by Region
      8.1 Global Immunotherapy Sales by Region
            8.1.1 Global Immunotherapy Sales by Region
            8.1.2 Global Immunotherapy Sales Market Share by Region
      8.2 Global Immunotherapy Market Size by Region
            8.2.1 Global Immunotherapy Market Size by Region
            8.2.2 Global Immunotherapy Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Immunotherapy Sales by Country
            8.3.2 North America Immunotherapy Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Immunotherapy Sales by Country
            8.4.2 Europe Immunotherapy Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Immunotherapy Sales by Region
            8.5.2 Asia Pacific Immunotherapy Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Immunotherapy Sales by Country
            8.6.2 South America Immunotherapy Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Immunotherapy Sales by Region
            8.7.2 Middle East and Africa Immunotherapy Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Immunotherapy Market Production by Region
      9.1 Global Production of Immunotherapy by Region(2020-2025)
      9.2 Global Immunotherapy Revenue Market Share by Region (2020-2025)
      9.3 Global Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Immunotherapy Production
            9.4.1 North America Immunotherapy Production Growth Rate (2020-2025)
            9.4.2 North America Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Immunotherapy Production
            9.5.1 Europe Immunotherapy Production Growth Rate (2020-2025)
            9.5.2 Europe Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Immunotherapy Production (2020-2025)
            9.6.1 Japan Immunotherapy Production Growth Rate (2020-2025)
            9.6.2 Japan Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Immunotherapy Production (2020-2025)
            9.7.1 China Immunotherapy Production Growth Rate (2020-2025)
            9.7.2 China Immunotherapy Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Abbvie
            10.1.1 Abbvie Basic Information
            10.1.2 Abbvie Immunotherapy Product Overview
            10.1.3 Abbvie Immunotherapy Product Market Performance
            10.1.4 Abbvie Business Overview
            10.1.5 Abbvie SWOT Analysis
            10.1.6 Abbvie Recent Developments
      10.2 AmgenInc.
            10.2.1 AmgenInc. Basic Information
            10.2.2 AmgenInc. Immunotherapy Product Overview
            10.2.3 AmgenInc. Immunotherapy Product Market Performance
            10.2.4 AmgenInc. Business Overview
            10.2.5 AmgenInc. SWOT Analysis
            10.2.6 AmgenInc. Recent Developments
      10.3 Biogen
            10.3.1 Biogen Basic Information
            10.3.2 Biogen Immunotherapy Product Overview
            10.3.3 Biogen Immunotherapy Product Market Performance
            10.3.4 Biogen Business Overview
            10.3.5 Biogen SWOT Analysis
            10.3.6 Biogen Recent Developments
      10.4 Bristol-Myers Squibb
            10.4.1 Bristol-Myers Squibb Basic Information
            10.4.2 Bristol-Myers Squibb Immunotherapy Product Overview
            10.4.3 Bristol-Myers Squibb Immunotherapy Product Market Performance
            10.4.4 Bristol-Myers Squibb Business Overview
            10.4.5 Bristol-Myers Squibb Recent Developments
      10.5 Celgene
            10.5.1 Celgene Basic Information
            10.5.2 Celgene Immunotherapy Product Overview
            10.5.3 Celgene Immunotherapy Product Market Performance
            10.5.4 Celgene Business Overview
            10.5.5 Celgene Recent Developments
      10.6 Johnson and Johnson
            10.6.1 Johnson and Johnson Basic Information
            10.6.2 Johnson and Johnson Immunotherapy Product Overview
            10.6.3 Johnson and Johnson Immunotherapy Product Market Performance
            10.6.4 Johnson and Johnson Business Overview
            10.6.5 Johnson and Johnson Recent Developments
      10.7 Merck
            10.7.1 Merck Basic Information
            10.7.2 Merck Immunotherapy Product Overview
            10.7.3 Merck Immunotherapy Product Market Performance
            10.7.4 Merck Business Overview
            10.7.5 Merck Recent Developments
      10.8 Novartis
            10.8.1 Novartis Basic Information
            10.8.2 Novartis Immunotherapy Product Overview
            10.8.3 Novartis Immunotherapy Product Market Performance
            10.8.4 Novartis Business Overview
            10.8.5 Novartis Recent Developments
      10.9 Pfizer
            10.9.1 Pfizer Basic Information
            10.9.2 Pfizer Immunotherapy Product Overview
            10.9.3 Pfizer Immunotherapy Product Market Performance
            10.9.4 Pfizer Business Overview
            10.9.5 Pfizer Recent Developments
      10.10 Roche
            10.10.1 Roche Basic Information
            10.10.2 Roche Immunotherapy Product Overview
            10.10.3 Roche Immunotherapy Product Market Performance
            10.10.4 Roche Business Overview
            10.10.5 Roche Recent Developments
  11 Immunotherapy Market Forecast by Region
      11.1 Global Immunotherapy Market Size Forecast
      11.2 Global Immunotherapy Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Immunotherapy Market Size Forecast by Country
            11.2.3 Asia Pacific Immunotherapy Market Size Forecast by Region
            11.2.4 South America Immunotherapy Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Immunotherapy by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Immunotherapy Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Immunotherapy by Type (2026-2033)
            12.1.2 Global Immunotherapy Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Immunotherapy by Type (2026-2033)
      12.2 Global Immunotherapy Market Forecast by Application (2026-2033)
            12.2.1 Global Immunotherapy Sales (K Units) Forecast by Application
            12.2.2 Global Immunotherapy Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Abbvie
AmgenInc.
Biogen
Bristol-Myers Squibb
Celgene
Johnson & Johnson
Merck
Novartis
Pfizer
Roche
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400